Vir Biotechnology Inc

NASDAQ:VIR   3:45:09 PM EDT
31.63
-1.25 (-3.80%)
Products

GSK And Vir Submit Emergency Use Authorization Application To FDA For Intramuscular Administration Of Sotrovimab For Early Treatment Of Covid-19

Published: 01/13/2022 14:40 GMT
Vir Biotechnology Inc (VIR) - Gsk and Vir Submit Emergency Use Authorization Application to FDA for Intramuscular Administration of Sotrovimab for the Early Treatment of Covid-19.
Vir - Submission of an Application to FDA Requesting an Amendment to Eua for Sotrovimab, to Include Intramuscular (im) Administration.